VDH: Meningococcal disease no longer an outbreak in Virginia
According to the Virginia Department of Health, Virginia is not experiencing an outbreak of meningococcal disease, a serious ...
Cavalier Daily2d
U.Va. student diagnosed with Meningococcal disease
Bonner said anyone exhibiting symptoms of the disease should make an appointment with Student Health and Wellness for ...
Science News5d
What experts say about childhood vaccines amid the Texas measles outbreak
As the Texas measles outbreak grows and HHS head RFK Jr. puts vaccines under new scrutiny, two experts answer questions about the public health tool.
Healio6d
FDA cancels meeting to pick flu vaccine components for next season
The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza ...
Neurology Advisor6d
Meningococcal Vaccination Recommended Before Switch to Ravulizumab in NMOSD
For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.
FDA cancels meeting to select flu strains for next season's shots
A Food and Drug Administration vaccine advisory committee meeting scheduled for March to select the strains to be included in ...
pulmonologyadvisor7d
FDA Approves More Broadly Protective Meningococcal Vaccine
The US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.
clinicaladvisor.com12d
Pentavalent Meningococcal Vaccine Penmenvy Gets FDA Approval
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
Medscape14d
Meningococcal Vaccines: A Neglected Topic in Travel Medicine?
Expert Rev Vaccines. 2009;8(10):1343-1350. Meningococcal disease epidemiology also displays seasonal variation, which is important when traveling across hemispheres. Disease incidence has been ...
Yahoo Finance14d
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)
On Friday, February 14, the FDA approved GSK plc’s (NYSE:GSK) Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25. The vaccine targets five major ...
Benzinga.com14d
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
The FDA approved GSK's Penmenvy vaccine for ages 10-25, targeting five major meningococcal serogroups: A, B, C, W, and Y. Phase 3 trials with 4,800 participants showed the vaccine has a safety ...
Pacific Daily News15d
FDA Approves More Broadly Protective Meningococcal Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive ...